Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

ClinicalTrials.gov ID: NCT01300208

Public ClinicalTrials.gov record NCT01300208. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Pilot, Multicenter, Sequential, Ascending Dose Study to Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is the first study in cutaneous lupus erythematosus subjects to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of CC-11050.

Study identification

NCT ID
NCT01300208
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1, 2010 (Actual)
Primary completion
Jan 1, 2013 (Actual)
Completion
Mar 1, 2013 (Actual)
Last update posted
Jun 23, 2020

2010 – 2013

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Northwest Arkansas Clinical Trials Center, PLLC Rogers Arkansas 72758 —
Dermatology Research Associates Los Angeles California 90045 —
Medderm Associates San Diego California 92103 —
Emory Univ. School of Medicine Atlanta Georgia 30322 —
Peachtree Dermatology Associates Research Center Atlanta Georgia 30327 —
Central Medaphase Inc Newnan Georgia 30263 —
Northwestern University Chicago Illinois 60611 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256 —
DermResearch, PLLC Louisville Kentucky 40217 —
Dermatology & Advanced Aesthetics Lake Charles Louisiana 70605 —
Central Dermatology, P.C. St Louis Missouri 63117 —
NYU Langone Medical Center New York New York 10016 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Penn State Hershey Dermatology Hershey Pennsylvania 17033 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
UT Southwestern Medical Center Dallas Dallas Texas 75390-9090 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01300208, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2020 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01300208 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →